Steven Murphy Highlights New Research Linking POTS Platelets to Storage Pool Deficiency
Steven Murphy, Medical Director, Concierge Medical Associates, shared a post on LinkedIn:
“Are POTS patients’ platelets different? Should we be avoiding PRP in them?
What about in patients with Long COVID and POTS?
An interesting research article was published
“Postural orthostatic tachycardia syndrome in post-COVID-19 long-hauler patients is associated with platelet storage pool deficiency”
Title: Postural orthostatic tachycardia syndrome in post-COVID-19 long-hauler patients is associated with platelet storage pool deficiency
Authors: William T. Gunning III, Saira Khan, John W. Spatafore, Beverly L. Karabin, Blair P. Grubb

Read more here.
Both POTS groups have δ-SPD, AKA dense (delta) granule storage pool deficiency. There also is a genetic version, but this was not assessed in this study.
PRP has 7 fundamental proteins: platelet derived growth factors (PDGF), transforming growth factor–β (TGF-β), vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), and adhesive proteins – fibrin, fibronectin, and vitronectin…. we think these are the main factors in the success of it.
But my main man Peter A. Everts, PhD, FRSM reviews even more factors.
Title: Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020
Authors: Peter Everts, Kentaro Onishi, Prathap Jayaram, José Fábio Lana, Kenneth Mautner

Read more here
Dense granules effect platelet activation and Alpha granules contain good stuff. I also add, mitochondria can travel between cells and I posit also help healing in the injured tissue.
But the problem I have is this: Both scenarios above point to platelets that are not “normal”: in long COVID POTS they may be chronically activated/exhausted, and in regular POTS they have intrinsic granule deficits. These features overlap with the concept of platelet senescence or aging. As platelets age (or undergo repeated activation), they lose granule content and responsiveness while gaining pro-inflammatory behavior.
A 2025 review on platelet aging notes that senescent platelets display reduced granule content, impaired responsiveness, and heightened pro-inflammatory factor release, all of which can compromise tissue repair processes.
So I ask all OBX brothers and sisters, what do you do with your POTS or Long COVID POTS patients?
I will be investigating this on my substack next week”

Stay updated with Hemostasis Today.
-
Jan 10, 2026, 08:56Shivanand Kumatagi Reflects on His Visit to Rela Hospital
-
Jan 10, 2026, 08:48Mitchell Elkind: Why Is The American Heart Association Holding a Brain Health Symposium?
-
Jan 10, 2026, 08:41Fiona Robinson Invites You to NBDF Webinar on Research Grants
-
Jan 10, 2026, 08:30Melissa Korn Takes Front Page Award for Her WSJ Piece on Experiencing a Pulmonary Embolism
-
Jan 10, 2026, 08:20Aymar Akilimali on Malaria in the Democratic Republic of Congo
-
Jan 9, 2026, 12:17Louise St Germain Bannon Invites You to Self-Nominate for the ISTH Council
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management
